Krebs Biochemicals & Industries Other Announcement
Krebs Biochemicals & Industries Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations, disclosing the distribution of equity stakes among shareholders.
ALFA Filings
Every announcement, straight from the exchange
Every Krebs Biochemicals & Industries other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Krebs Biochemicals & Industries Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations, disclosing the distribution of equity stakes among shareholders.
Krebs Biochemicals submitted its Annual Secretarial Compliance Report for the financial year ended March 2026. The report details governance compliance and historical penalties for board composition.
Krebs Biochemicals & Industries Limited submitted the RTA certificate under Regulation 74(5) of SEBI DP Regulations for the quarter ended March 31, 2026. The filing confirms compliance regarding the dematerialization and rematerialization of securities during the period.